Literature DB >> 8285765

Double blind trial of recombinant human erythropoietin in preterm infants.

R H Nicholson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8285765      PMCID： PMC1029605          DOI： 10.1136/adc.69.5_spec_no.542

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

1.  Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

Authors:  R K Ohls; R D Christensen
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

2.  Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.

Authors:  V Carnielli; G Montini; R Da Riol; R Dall'Amico; F Cantarutti
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

3.  Double blind trial of recombinant human erythropoietin in preterm infants.

Authors:  A J Emmerson; H J Coles; C M Stern; T C Pearson
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

4.  Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.

Authors:  K M Shannon; W C Mentzer; R I Abels; M Wertz; J Thayer-Moriyama; W Y Li; D Thompson; S Decelle; R H Phibbs
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.